Tag: Mount Sinai Health System;Icahn School of Medicine at Mount Sinai;Atopic Dermatitis;Eczema;Emma Guttman-Yassky;Dermatology;Center of Excellence in Eczema;Laboratory of Inflammatory Skin Diseases

Newswise — Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the…

Read more New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results